141 related articles for article (PubMed ID: 34418452)
1. Metoprine, a histamine N-methyltransferase inhibitor, attenuates methamphetamine-induced hyperlocomotion via activation of histaminergic neurotransmission in mice.
Kitanaka N; Hall FS; Kobori S; Kushihara S; Oyama H; Sasaoka Y; Takechi M; Tanaka KI; Tomita K; Igarashi K; Nishiyama N; Sato T; Uhl GR; Kitanaka J
Pharmacol Biochem Behav; 2021 Oct; 209():173257. PubMed ID: 34418452
[TBL] [Abstract][Full Text] [Related]
2. Blockade of brain histamine metabolism alters methamphetamine-induced expression pattern of stereotypy in mice via histamine H1 receptors.
Kitanaka J; Kitanaka N; Tatsuta T; Morita Y; Takemura M
Neuroscience; 2007 Jul; 147(3):765-77. PubMed ID: 17570600
[TBL] [Abstract][Full Text] [Related]
3. Metoprine induced behavioral modifications and brain regional histamine increase in WAG/Rij and Wistar rats.
Samotaeva IS; Birioukova LM; Midzyanovskaya IS; Kuznetsova GD; Bazyan AS; Tuomisto L
Epilepsy Res; 2012 Aug; 101(1-2):148-56. PubMed ID: 22503455
[TBL] [Abstract][Full Text] [Related]
4. Effects of (S)-alpha -fluoromethylhistidine and metoprine on locomotor activity and brain histamine content in mice.
Sakai N; Onodera K; Maeyama K; Yanai K; Watanabe T
Life Sci; 1992; 51(6):397-405. PubMed ID: 1635419
[TBL] [Abstract][Full Text] [Related]
5. Metoprine, an inhibitor of histamine N-methyltransferase but not catechol-O-methyltransferase, suppresses feeding in sated and in food deprived rats.
Lecklin A; Tuomisto L; MacDonald E
Methods Find Exp Clin Pharmacol; 1995; 17(1):47-52. PubMed ID: 7542717
[TBL] [Abstract][Full Text] [Related]
6. In vivo evaluation of effects of histamine H
Kitanaka J; Kitanaka N; Hall FS; Amatsu Y; Hashimoto K; Hisatomi E; Kitao E; Mimura M; Nakamura M; Ozawa R; Sato M; Tagami K; Uhl GR; Takemura M
Brain Res; 2020 Aug; 1740():146873. PubMed ID: 32387137
[TBL] [Abstract][Full Text] [Related]
7. Cardiac and regional haemodynamic effects of histamine N-methyltransferase inhibitor metoprine in haemorrhage-shocked rats.
Jochem J
Inflamm Res; 2004 Jul; 53(7):316-23. PubMed ID: 15241567
[TBL] [Abstract][Full Text] [Related]
8. Agmatine attenuates methamphetamine-induced hyperlocomotion and stereotyped behavior in mice.
Kitanaka N; Kitanaka J; Hall FS; Uhl GR; Watabe K; Kubo H; Takahashi H; Tanaka K; Nishiyama N; Takemura M
Behav Pharmacol; 2014 Apr; 25(2):158-65. PubMed ID: 24557322
[TBL] [Abstract][Full Text] [Related]
9. Changes in the rat brain histamine content following metoprine and other histamine-methyltransferase (HMT) inhibitors.
Zawilska J; Nowak JZ
Pol J Pharmacol Pharm; 1985; 37(6):821-30. PubMed ID: 3832018
[TBL] [Abstract][Full Text] [Related]
10. Histamine H3 receptor agonists decrease hypothalamic histamine levels and increase stereotypical biting in mice challenged with methamphetamine.
Kitanaka J; Kitanaka N; Hall FS; Uhl GR; Tatsuta T; Morita Y; Tanaka K; Nishiyama N; Takemura M
Neurochem Res; 2011 Oct; 36(10):1824-33. PubMed ID: 21573995
[TBL] [Abstract][Full Text] [Related]
11. Brain Histamine N-Methyltransferase As a Possible Target of Treatment for Methamphetamine Overdose.
Kitanaka J; Kitanaka N; Hall FS; Uhl GR; Takemura M
Drug Target Insights; 2016; 10():1-7. PubMed ID: 26966348
[TBL] [Abstract][Full Text] [Related]
12. The effect of metoprine on glucoprivic feeding induced by 2-deoxy-D-glucose.
Lecklin A; Järvikylä M; Tuomisto L
Pharmacol Biochem Behav; 1994 Dec; 49(4):853-7. PubMed ID: 7886098
[TBL] [Abstract][Full Text] [Related]
13. Psychotomimetic-like behavioral effects of memantine in the mouse.
Kitanaka N; Kitanaka J; Hall FS; Kubota Y; Mimura Y; Ogura S; Okada Y; Uhl GR; Takemura M
Biomed Pharmacother; 2018 Apr; 100():116-123. PubMed ID: 29427922
[TBL] [Abstract][Full Text] [Related]
14. The blockade of H1 receptors attenuates the suppression of feeding and diuresis induced by inhibition of histamine catabolism.
Lecklin A; Tuomisto L
Pharmacol Biochem Behav; 1998 Mar; 59(3):753-8. PubMed ID: 9512082
[TBL] [Abstract][Full Text] [Related]
15. Histaminergic modulation of acoustically induced running behavior in rats.
Vinogradova LV; Shatskova AB; Tuomisto L
Brain Res; 2007 May; 1148():198-204. PubMed ID: 17362890
[TBL] [Abstract][Full Text] [Related]
16. Pretreatment with l-histidine produces a shift from methamphetamine-induced stereotypical biting to persistent locomotion in mice.
Kitanaka J; Kitanaka N; Tatsuta T; Miyoshi A; Koumoto A; Tanaka K; Nishiyama N; Morita Y; Takemura M
Pharmacol Biochem Behav; 2010 Jan; 94(3):464-70. PubMed ID: 19895842
[TBL] [Abstract][Full Text] [Related]
17. Tetrabenazine, a vesicular monoamine transporter-2 inhibitor, attenuates morphine-induced hyperlocomotion in mice through alteration of dopamine and 5-hydroxytryptamine turnover in the cerebral cortex.
Kitanaka N; Kitanaka J; Hall FS; Kandori T; Murakami A; Muratani K; Nakano T; Uhl GR; Takemura M
Pharmacol Biochem Behav; 2018 Sep; 172():9-16. PubMed ID: 30017858
[TBL] [Abstract][Full Text] [Related]
18. Lack of effect of anticonvulsant topiramate on methamphetamine-induced stereotypy and rewarding property in mice.
Tatsuta T; Kitanaka N; Kitanaka J; Morita Y; Takemura M
Pharmacol Biochem Behav; 2007 May; 87(1):48-55. PubMed ID: 17482247
[TBL] [Abstract][Full Text] [Related]
19. Sigma1 receptor antagonists determine the behavioral pattern of the methamphetamine-induced stereotypy in mice.
Kitanaka J; Kitanaka N; Tatsuta T; Hall FS; Uhl GR; Tanaka K; Nishiyama N; Morita Y; Takemura M
Psychopharmacology (Berl); 2009 May; 203(4):781-92. PubMed ID: 19052726
[TBL] [Abstract][Full Text] [Related]
20. Effect of modified brain histamine contents on prolactin and thyrotropin secretion in male rats.
Tuominen RK; Tuomisto L; Männistö PT
Eur J Endocrinol; 1996 Feb; 134(2):209-14. PubMed ID: 8630521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
